BridgeBio is significantly advanced the progress of a novel treatment for cardiac amyloidosis, utilizing Attruby. Preliminary clinical results reveals potential improvements for individuals diagnosed from the https://bridgebio177863.dailyblogzz.com/42607860/bridgebio-advances-amyloidosis-treatment-through-the-drug